Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study
Identifieur interne : 003379 ( Main/Exploration ); précédent : 003378; suivant : 003380Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study
Auteurs : Johannes R. Bogner [Allemagne] ; Ammar Kutaiman ; Melanie Esguerra-Alcalen [Philippines] ; Stephanie Heldner [Allemagne] ; Pierre Arvis [France]Source :
- Advances in Therapy [ 0741-238X ] ; 2013.
Abstract
ARTOS was an international, prospective, non-interventional, non-controlled observational study designed to determine the effectiveness, safety, and tolerability of moxifloxacin under daily-life conditions in patients with complicated skin and skin structure infections (cSSSIs) treated in Europe, the Middle East, and Asia–Pacific region.
Eligible patients included males and females who were hospitalized patients or outpatients requiring antibiotic therapy for cSSSIs and for whom the treating physician had elected to begin moxifloxacin therapy in accordance with its approved indications. Patients were assessed before therapy and then at one or two follow-up visits. Effectiveness was assessed with respect to improvement and resolution of signs and symptoms of cSSSIs and safety with respect to the nature and frequency of adverse events and adverse drug reactions.
A total of 6,594 patients were enrolled of whom 5,444 had data available for analysis; 4,692 patients received sequential intravenous/oral (IV/PO) moxifloxacin and 752 exclusively IV therapy. A majority of patients were aged between 40 and 79 years and had one or more comorbid conditions. Post-surgical wound infection, skin abscess, and diabetic foot infection were the cSSSIs most frequently diagnosed and treated with moxifloxacin, with almost 90% of infections rated moderate or severe. Treating physicians chose sequential moxifloxacin 400 mg for most patients, switching from IV to PO after 3–4 days. On average, treatment was maintained for 10 days. Treatment with moxifloxacin was associated with rapid relief in symptoms, with 93.2% of patients experiencing either complete resolution of symptoms or improvement at follow-up. Moxifloxacin was well tolerated with adverse drug reactions occurring in only 2% of patients.
This study, conducted in a ‘real-world’ setting, confirms the effectiveness and safety of moxifloxacin in the treatment of a wide spectrum of cSSSIs seen in routine clinical practice.
Url:
DOI: 10.1007/s12325-013-0038-z
PubMed: 23797470
PubMed Central: 3706718
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000B87
- to stream Pmc, to step Curation: 000B86
- to stream Pmc, to step Checkpoint: 002137
- to stream Ncbi, to step Merge: 005A68
- to stream Ncbi, to step Curation: 005A68
- to stream Ncbi, to step Checkpoint: 005A68
- to stream Main, to step Merge: 003385
- to stream Main, to step Curation: 003379
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study</title>
<author><name sortKey="Bogner, Johannes R" sort="Bogner, Johannes R" uniqKey="Bogner J" first="Johannes R." last="Bogner">Johannes R. Bogner</name>
<affiliation wicri:level="3"><nlm:aff id="Aff1">Infektionsabteilung Med Klinik und Poliklinik IV, University Hospital of Munich, Munich, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Infektionsabteilung Med Klinik und Poliklinik IV, University Hospital of Munich, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kutaiman, Ammar" sort="Kutaiman, Ammar" uniqKey="Kutaiman A" first="Ammar" last="Kutaiman">Ammar Kutaiman</name>
<affiliation><nlm:aff id="Aff2">Department of General and Vascular Surgery, Al Noor Hospital, Abu Dhabi, UAE</nlm:aff>
<wicri:noCountry code="subfield">UAE</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Esguerra Alcalen, Melanie" sort="Esguerra Alcalen, Melanie" uniqKey="Esguerra Alcalen M" first="Melanie" last="Esguerra-Alcalen">Melanie Esguerra-Alcalen</name>
<affiliation wicri:level="1"><nlm:aff id="Aff3">Department of Surgery, San Juan De Dios Hospital, Pasay City, Philippines</nlm:aff>
<country xml:lang="fr">Philippines</country>
<wicri:regionArea>Department of Surgery, San Juan De Dios Hospital, Pasay City</wicri:regionArea>
<wicri:noRegion>Pasay City</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Heldner, Stephanie" sort="Heldner, Stephanie" uniqKey="Heldner S" first="Stephanie" last="Heldner">Stephanie Heldner</name>
<affiliation wicri:level="3"><nlm:aff id="Aff4">Bayer Pharma AG, Berlin, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Bayer Pharma AG, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arvis, Pierre" sort="Arvis, Pierre" uniqKey="Arvis P" first="Pierre" last="Arvis">Pierre Arvis</name>
<affiliation wicri:level="1"><nlm:aff id="Aff5">Bayer Santé, Loos, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Bayer Santé, Loos</wicri:regionArea>
<wicri:noRegion>Loos</wicri:noRegion>
<wicri:noRegion>Loos</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23797470</idno>
<idno type="pmc">3706718</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706718</idno>
<idno type="RBID">PMC:3706718</idno>
<idno type="doi">10.1007/s12325-013-0038-z</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">000B87</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B87</idno>
<idno type="wicri:Area/Pmc/Curation">000B86</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000B86</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002137</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002137</idno>
<idno type="wicri:Area/Ncbi/Merge">005A68</idno>
<idno type="wicri:Area/Ncbi/Curation">005A68</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005A68</idno>
<idno type="wicri:doubleKey">0741-238X:2013:Bogner J:moxifloxacin:in:complicated</idno>
<idno type="wicri:Area/Main/Merge">003385</idno>
<idno type="wicri:Area/Main/Curation">003379</idno>
<idno type="wicri:Area/Main/Exploration">003379</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study</title>
<author><name sortKey="Bogner, Johannes R" sort="Bogner, Johannes R" uniqKey="Bogner J" first="Johannes R." last="Bogner">Johannes R. Bogner</name>
<affiliation wicri:level="3"><nlm:aff id="Aff1">Infektionsabteilung Med Klinik und Poliklinik IV, University Hospital of Munich, Munich, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Infektionsabteilung Med Klinik und Poliklinik IV, University Hospital of Munich, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kutaiman, Ammar" sort="Kutaiman, Ammar" uniqKey="Kutaiman A" first="Ammar" last="Kutaiman">Ammar Kutaiman</name>
<affiliation><nlm:aff id="Aff2">Department of General and Vascular Surgery, Al Noor Hospital, Abu Dhabi, UAE</nlm:aff>
<wicri:noCountry code="subfield">UAE</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Esguerra Alcalen, Melanie" sort="Esguerra Alcalen, Melanie" uniqKey="Esguerra Alcalen M" first="Melanie" last="Esguerra-Alcalen">Melanie Esguerra-Alcalen</name>
<affiliation wicri:level="1"><nlm:aff id="Aff3">Department of Surgery, San Juan De Dios Hospital, Pasay City, Philippines</nlm:aff>
<country xml:lang="fr">Philippines</country>
<wicri:regionArea>Department of Surgery, San Juan De Dios Hospital, Pasay City</wicri:regionArea>
<wicri:noRegion>Pasay City</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Heldner, Stephanie" sort="Heldner, Stephanie" uniqKey="Heldner S" first="Stephanie" last="Heldner">Stephanie Heldner</name>
<affiliation wicri:level="3"><nlm:aff id="Aff4">Bayer Pharma AG, Berlin, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Bayer Pharma AG, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arvis, Pierre" sort="Arvis, Pierre" uniqKey="Arvis P" first="Pierre" last="Arvis">Pierre Arvis</name>
<affiliation wicri:level="1"><nlm:aff id="Aff5">Bayer Santé, Loos, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Bayer Santé, Loos</wicri:regionArea>
<wicri:noRegion>Loos</wicri:noRegion>
<wicri:noRegion>Loos</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Advances in Therapy</title>
<idno type="ISSN">0741-238X</idno>
<idno type="eISSN">1865-8652</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Introduction</title>
<p>ARTOS was an international, prospective, non-interventional, non-controlled observational study designed to determine the effectiveness, safety, and tolerability of moxifloxacin under daily-life conditions in patients with complicated skin and skin structure infections (cSSSIs) treated in Europe, the Middle East, and Asia–Pacific region.</p>
</sec>
<sec><title>Methods</title>
<p>Eligible patients included males and females who were hospitalized patients or outpatients requiring antibiotic therapy for cSSSIs and for whom the treating physician had elected to begin moxifloxacin therapy in accordance with its approved indications. Patients were assessed before therapy and then at one or two follow-up visits. Effectiveness was assessed with respect to improvement and resolution of signs and symptoms of cSSSIs and safety with respect to the nature and frequency of adverse events and adverse drug reactions.</p>
</sec>
<sec><title>Results</title>
<p>A total of 6,594 patients were enrolled of whom 5,444 had data available for analysis; 4,692 patients received sequential intravenous/oral (IV/PO) moxifloxacin and 752 exclusively IV therapy. A majority of patients were aged between 40 and 79 years and had one or more comorbid conditions. Post-surgical wound infection, skin abscess, and diabetic foot infection were the cSSSIs most frequently diagnosed and treated with moxifloxacin, with almost 90% of infections rated moderate or severe. Treating physicians chose sequential moxifloxacin 400 mg for most patients, switching from IV to PO after 3–4 days. On average, treatment was maintained for 10 days. Treatment with moxifloxacin was associated with rapid relief in symptoms, with 93.2% of patients experiencing either complete resolution of symptoms or improvement at follow-up. Moxifloxacin was well tolerated with adverse drug reactions occurring in only 2% of patients.</p>
</sec>
<sec><title>Conclusions</title>
<p>This study, conducted in a ‘real-world’ setting, confirms the effectiveness and safety of moxifloxacin in the treatment of a wide spectrum of cSSSIs seen in routine clinical practice.</p>
</sec>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Engemann, Jj" uniqKey="Engemann J">JJ Engemann</name>
</author>
<author><name sortKey="Carmeli, Y" uniqKey="Carmeli Y">Y Carmeli</name>
</author>
<author><name sortKey="Cosgrove, Se" uniqKey="Cosgrove S">SE Cosgrove</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Leaper, Dj" uniqKey="Leaper D">DJ Leaper</name>
</author>
<author><name sortKey="Van Goor, H" uniqKey="Van Goor H">H van Goor</name>
</author>
<author><name sortKey="Reilly, J" uniqKey="Reilly J">J Reilly</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lipsky, Ba" uniqKey="Lipsky B">BA Lipsky</name>
</author>
<author><name sortKey="Weigelt, Ja" uniqKey="Weigelt J">JA Weigelt</name>
</author>
<author><name sortKey="Gupta, V" uniqKey="Gupta V">V Gupta</name>
</author>
<author><name sortKey="Killian, A" uniqKey="Killian A">A Killian</name>
</author>
<author><name sortKey="Peng, Mm" uniqKey="Peng M">MM Peng</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Cainzos, M" uniqKey="Cainzos M">M Cainzos</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Napolitano, Lm" uniqKey="Napolitano L">LM Napolitano</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Moet, Gj" uniqKey="Moet G">GJ Moet</name>
</author>
<author><name sortKey="Jones, Rn" uniqKey="Jones R">RN Jones</name>
</author>
<author><name sortKey="Biedenbacj, Dj" uniqKey="Biedenbacj D">DJ Biedenbacj</name>
</author>
<author><name sortKey="Stilwell, Mg" uniqKey="Stilwell M">MG Stilwell</name>
</author>
<author><name sortKey="Fritsche, Tr" uniqKey="Fritsche T">TR Fritsche</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Brook, I" uniqKey="Brook I">I Brook</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Eron, Lj" uniqKey="Eron L">LJ Eron</name>
</author>
<author><name sortKey="Lipsky, Ba" uniqKey="Lipsky B">BA Lipsky</name>
</author>
<author><name sortKey="Low, De" uniqKey="Low D">DE Low</name>
</author>
<author><name sortKey="Nathwani, D" uniqKey="Nathwani D">D Nathwani</name>
</author>
<author><name sortKey="Tice, Ad" uniqKey="Tice A">AD Tice</name>
</author>
<author><name sortKey="Volturo, Ga" uniqKey="Volturo G">GA Volturo</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Stevens, Dl" uniqKey="Stevens D">DL Stevens</name>
</author>
<author><name sortKey="Bisno, Al" uniqKey="Bisno A">AL Bisno</name>
</author>
<author><name sortKey="Chambers, Hf" uniqKey="Chambers H">HF Chambers</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Liu, C" uniqKey="Liu C">C Liu</name>
</author>
<author><name sortKey="Bayer, A" uniqKey="Bayer A">A Bayer</name>
</author>
<author><name sortKey="Cosgrove, Se" uniqKey="Cosgrove S">SE Cosgrove</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lipsky, Ba" uniqKey="Lipsky B">BA Lipsky</name>
</author>
<author><name sortKey="Peters, Ej" uniqKey="Peters E">EJ Peters</name>
</author>
<author><name sortKey="Berendt, Ar" uniqKey="Berendt A">AR Berendt</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Giordano, P" uniqKey="Giordano P">P Giordano</name>
</author>
<author><name sortKey="Weber, K" uniqKey="Weber K">K Weber</name>
</author>
<author><name sortKey="Gesin, G" uniqKey="Gesin G">G Gesin</name>
</author>
<author><name sortKey="Kubert, J" uniqKey="Kubert J">J Kubert</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Guay, D" uniqKey="Guay D">D Guay</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Vick Fragoso, R" uniqKey="Vick Fragoso R">R Vick-Fragoso</name>
</author>
<author><name sortKey="Hernandez Oliva, G" uniqKey="Hernandez Oliva G">G Hernández-Oliva</name>
</author>
<author><name sortKey="Cruz Alcazar, J" uniqKey="Cruz Alcazar J">J Cruz-Alcázar</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Giordano, P" uniqKey="Giordano P">P Giordano</name>
</author>
<author><name sortKey="Song, J" uniqKey="Song J">J Song</name>
</author>
<author><name sortKey="Pertel, P" uniqKey="Pertel P">P Pertel</name>
</author>
<author><name sortKey="Herrington, J" uniqKey="Herrington J">J Herrington</name>
</author>
<author><name sortKey="Kowalsky, S" uniqKey="Kowalsky S">S Kowalsky</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gyssens, Ic" uniqKey="Gyssens I">IC Gyssens</name>
</author>
<author><name sortKey="Dryden, M" uniqKey="Dryden M">M Dryden</name>
</author>
<author><name sortKey="Kujath, P" uniqKey="Kujath P">P Kujath</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Jepsen, P" uniqKey="Jepsen P">P Jepsen</name>
</author>
<author><name sortKey="Johnsen, Sp" uniqKey="Johnsen S">SP Johnsen</name>
</author>
<author><name sortKey="Gillman, Mw" uniqKey="Gillman M">MW Gillman</name>
</author>
<author><name sortKey="S Rensen, Ht" uniqKey="S Rensen H">HT Sørensen</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Suvarna, V" uniqKey="Suvarna V">V Suvarna</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Schaper, Nc" uniqKey="Schaper N">NC Schaper</name>
</author>
<author><name sortKey="Dryden, M" uniqKey="Dryden M">M Dryden</name>
</author>
<author><name sortKey="Kujath, P" uniqKey="Kujath P">P Kujath</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Jenkins, Tc" uniqKey="Jenkins T">TC Jenkins</name>
</author>
<author><name sortKey="Sabel, Al" uniqKey="Sabel A">AL Sabel</name>
</author>
<author><name sortKey="Sarcone, Ee" uniqKey="Sarcone E">EE Sarcone</name>
</author>
<author><name sortKey="Price, Cs" uniqKey="Price C">CS Price</name>
</author>
<author><name sortKey="Mehler, Ps" uniqKey="Mehler P">PS Mehler</name>
</author>
<author><name sortKey="Burman, Wj" uniqKey="Burman W">WJ Burman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Tulkens, Pm" uniqKey="Tulkens P">PM Tulkens</name>
</author>
<author><name sortKey="Arvis, P" uniqKey="Arvis P">P Arvis</name>
</author>
<author><name sortKey="Kruesmann, F" uniqKey="Kruesmann F">F Kruesmann</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Concia, E" uniqKey="Concia E">E Concia</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>France</li>
<li>Philippines</li>
</country>
<region><li>Bavière</li>
<li>Berlin</li>
<li>District de Haute-Bavière</li>
</region>
<settlement><li>Berlin</li>
<li>Munich</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Kutaiman, Ammar" sort="Kutaiman, Ammar" uniqKey="Kutaiman A" first="Ammar" last="Kutaiman">Ammar Kutaiman</name>
</noCountry>
<country name="Allemagne"><region name="Bavière"><name sortKey="Bogner, Johannes R" sort="Bogner, Johannes R" uniqKey="Bogner J" first="Johannes R." last="Bogner">Johannes R. Bogner</name>
</region>
<name sortKey="Heldner, Stephanie" sort="Heldner, Stephanie" uniqKey="Heldner S" first="Stephanie" last="Heldner">Stephanie Heldner</name>
</country>
<country name="Philippines"><noRegion><name sortKey="Esguerra Alcalen, Melanie" sort="Esguerra Alcalen, Melanie" uniqKey="Esguerra Alcalen M" first="Melanie" last="Esguerra-Alcalen">Melanie Esguerra-Alcalen</name>
</noRegion>
</country>
<country name="France"><noRegion><name sortKey="Arvis, Pierre" sort="Arvis, Pierre" uniqKey="Arvis P" first="Pierre" last="Arvis">Pierre Arvis</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003379 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003379 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:3706718 |texte= Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23797470" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |